Appendix cancer natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 89: Line 89:
** Spread of the tumor beyond the left lower quadrant
** Spread of the tumor beyond the left lower quadrant
** Presence of malignant cells outside of the visceral peritoneum of the appendix
** Presence of malignant cells outside of the visceral peritoneum of the appendix
* '''Poor prognostic factors in the presence of'''  '''pseudomyxoma peritonei''' are as follows:   
* '''Poor prognostic factors in the presence of'''  '''[[pseudomyxoma peritonei]]''' are as follows:   
** Abdominal distension
** Abdominal distension
** Weight loss
** Weight loss

Revision as of 20:02, 18 January 2019

Appendix cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Differentiating Appendix cancer from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

MRI

CT scan

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Appendix cancer natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Appendix cancer natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Appendix cancer natural history, complications and prognosis

CDC on Appendix cancer natural history, complications and prognosis

Appendix cancer natural history, complications and prognosis in the news

Blogs on Appendix cancer natural history, complications and prognosis

Directions to Hospitals Treating Appendix cancer

Risk calculators and risk factors for Appendix cancer natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]


Overview

  • Because of the location and size of appendix most of the patients with appendix cancer may be initially asymptomatic. Early clinical features might include periodical unspecific abdominal pain, bloating, and nausea. Most of appendix cancer cases are discovered after surgical or histological evaluation of a patient with acute appendicitis, or are an accidental finding in imaging studies for the other reasons. If left untreated, the majority of patients with appendix cancer may progress to develop peritoneal carcinomatosis and metastases. Prognosis is generally excellent and good in carcinoid tumors and adenocarcinomae respectively. Prognostic factors including tumor stage, tumor size, histologic as well genetic characteristics of appendiceal tumors are discussed in details below.

Natural History, Complications, and Prognosis

Natural History

  • The majority of patients with appendix cancer may be initially asymptomatic.
  • Early clinical features might include periodical unspecific abdominal pain, bloating, and nausea.
  • Most of appendix cancer cases are discovered after surgical or histological evaluation of a patient with acute appendicitis, or are an accidental finding in imaging studies for the other reasons.
  • If left untreated, the majority of patients with appendix cancer may progress to develop peritoneal carcinomatosis and metastases

Complications

Prognosis

  • Major prognostic factors are tumor stage, tumor size, histologic as well genetic characteristics of appendiceal tumors.
  • Prognosis is generally excellent and good in carcinoid tumors and adenocarcinomae respectively.
  • The overall 5-year survival rate for adenocarcinoma of appendix is approximately 71% (see the Table below). [1]
  • Tumor size plays a crucial role in determining prognosis.
    • Most of the appendiceal tumors are less than 2 cm in size and have a quite favorable prognosis since they barely metastasize.[2][3]
  • The prognosis varies with the histology of tumor.
  • Carcinoid tumors are associated with a better prognosis prognosis among patients with appendical cancer.
  • Localized carcinoid tumors are associated with the most favorable prognosis.
  • The presence of tubular pathology is also associated with a particularly good prognosis among patients with appendix adenocarcinoma.
Five year survival rates
Carcinoid tumors
  • localized disease 94%
  • Regional disease 85%
  • Distant metastases 34%
  • Goblet cell 12.5%
  • Tubular tumors are benign clinically
Adenocarcinoma
Nonmucinus
  • Localized 95%
  • Distant metastasis 0%*
Mucinous adenocarcinoma
  • localized 80%
  • Distant metastasis 51%*
* Shows that mucinous adenocarcinomae are less aggressive than nunmnucinous tumors
  • Poor prognostic factors for appendiceal adenocarcinoma are as follows:
    • Advanced stage
    • High grade
    • Nonmucinous histology
    • Spread of the tumor beyond the left lower quadrant
    • Presence of malignant cells outside of the visceral peritoneum of the appendix
  • Poor prognostic factors in the presence of pseudomyxoma peritonei are as follows:
    • Abdominal distension
    • Weight loss
    • High histological grade
    • Morphological evidence of invasion of underlying structures
  • Genetic prognostic markers of appendiceal cancers are as follows:
    • Genetic studies revolutionized cancer treatment; appendix cancer is not an exception.
    • Traditionally appandiceal cancers were approached the same as colorectal cancers.
      • Recent genetic studies demonstrated that appendiceal tumors are clearly differ from colorectal cancers. [4]=Presence of mutated TP53 and APC genes were significantly lower in appendiceal cancers compared to colorectal cancers.
    • It has been shown that mutation profiles are associated with the patients’ prognosis. [5]
      • Mutations in the TP53 significantly decrease life expectancy in patients with appendix cancer.
      • Regardless of tumor grade, Tp 53 mutations were associated with poorer outcomes.
      • Patients with GNAS mutations had a life expectancy of 10 years after diagnosis.
      • Appendiceal tumors with GNAS mutations rarely develop into high-grade tumors.

References

  1. Modlin IM, Sandor A (1997). "An analysis of 8305 cases of carcinoid tumors". Cancer. 79 (4): 813–29. PMID 9024720.
  2. Irvin M. Modlin, Kevin D. Lye & Mark Kidd (2003). "A 5-decade analysis of 13,715 carcinoid tumors". Cancer. 97 (4): 934–959. doi:10.1002/cncr.11105. PMID 12569593. Unknown parameter |month= ignored (help)
  3. A poorer survival has been reported for the black patients with carcinoid tumors. <ref name=":0">Melinda A. Maggard, Jessica B. O'Connell & Clifford Y. Ko (2004). "Updated population-based review of carcinoid tumors". Annals of surgery. 240 (1): 117–122. PMID 15213627. Unknown parameter |month= ignored (help)
  4. </nowiki>Levine EA, Blazer DG, Kim MK, Shen P, Stewart JH, Guy C; et al. (2012). "Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes". J Am Coll Surg. 214 (4): 599–606, discussion 606-7. doi:10.1016/j.jamcollsurg.2011.12.028. PMC 3768122. PMID 22342786.
  5. Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW; et al. (2016). "Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix". J Am Coll Surg. 222 (4): 493–503. doi:10.1016/j.jamcollsurg.2015.12.012. PMC 4808611. PMID 26821970.

Template:WH Template:WS